Cargando…

Bone Marrow Defects and Platelet Function: A Focus on MDS and CLL

The bloodstream typically contains >500 billion anucleate circulating platelets, derived from megakaryocytes in the bone marrow. This review will focus on two interesting aspects of bone marrow dysfunction and how this impacts on the quality of circulating platelets. In this regard, although mega...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luu, Sarah, Gardiner, Elizabeth E., Andrews, Robert K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977120/ https://www.ncbi.nlm.nih.gov/pubmed/29783667 http://dx.doi.org/10.3390/cancers10050147

Ejemplares similares

Multi Cytogenetic Changes in a Patient as Co-Existing MDS and CLL Progresses
por: Li, Xiangxin, et al.
Publicado: (2021)

PB1989: STUDY ON THE RELATIONSHIP BETWEEN MDS AND ABNORMAL LIPID METABOLISM IN BONE MARROW MICROENVIRONMENT
por: LI, Yuchun, et al.
Publicado: (2023)

Bioenergetic Profiling of the Differentiating Human MDS Myeloid Lineage with Low and High Bone Marrow Blast Counts
por: Poulaki, Aikaterini, et al.
Publicado: (2020)

Direct in vivo Evidence for Increased Proliferation of CLL Cells in Lymph Nodes Compared to Bone Marrow and Peripheral Blood
por: Herndon, Thomas M., et al.
Publicado: (2017)

Clonal MDS/AML cells with enhanced TWIST1 expression reprogram the differentiation of bone marrow MSCs
por: Li, Hongjiao, et al.
Publicado: (2023)

Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy
por: Poon, Zhiyong, et al.
Publicado: (2018)

Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS
por: Mei, Y, et al.
Publicado: (2018)

Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium
por: Altrock, Eva, et al.
Publicado: (2023)

Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy
por: Poon, Zhiyong, et al.
Publicado: (2019)

Prognostic Impact of Immunohistochemical p53 Expression in Bone Marrow Biopsy in Higher Risk MDS: a Pilot Study
por: Molteni, Alfredo, et al.
Publicado: (2019)

Comparison between the effects of platelet-rich plasma and bone marrow concentrate on defect consolidation in the rabbit tibia
por: Batista, Marco Antonio, et al.
Publicado: (2011)

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020)

Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC
por: Decker, William K., et al.
Publicado: (2012)

Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression
por: Weickert, Marie-Theresa, et al.
Publicado: (2021)

Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients
por: Strapatsas, Judith, et al.
Publicado: (2021)

The Bone Regeneration Using Bone Marrow Stromal Cells with Moderate Concentration Platelet-Rich Plasma in Femoral Segmental Defect of Rats
por: Yamakawa, Junichi, et al.
Publicado: (2017)

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib
por: Kazianka, L, et al.
Publicado: (2017)

Bone Marrow Aspiration Concentrate and Platelet Rich Plasma for Osteochondral Repair in a Porcine Osteochondral Defect Model
por: Betsch, Marcel, et al.
Publicado: (2013)

Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivo
por: Purroy, Noelia, et al.
Publicado: (2014)

Bone Marrow Aspirate Concentrate-Enhanced Marrow Stimulation of Chondral Defects
por: Madry, Henning, et al.
Publicado: (2017)

Autologous bone marrow clot as an alternative to autograft for bone defect healing
por: Lim, Z. X. H., et al.
Publicado: (2019)

Regulation of platelet activation and thrombus formation by reactive oxygen species
por: Qiao, Jianlin, et al.
Publicado: (2017)

Healing capacity of bone marrow mesenchymal stem cells versus platelet-rich fibrin in tibial bone defects of albino rats: an in vivo study
por: Rady, Dina, et al.
Publicado: (2018)

P699: MAGROLIMAB ALTERS THE TUMOR MICROENVIRONMENT TO IMPROVE BONE MARROW FUNCTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)
por: Johnson, Lisa, et al.
Publicado: (2023)

Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8(+) T cell immunity in CLL and MDS patients
por: Hernandez, Susana Patricia Amaya, et al.
Publicado: (2023)

Combination of bone marrow aspirate, cancellous bone allograft, and platelet-rich plasma as an alternative solution to critical-sized diaphyseal bone defect: A case series
por: Utomo, Dwikora Novembri, et al.
Publicado: (2019)

Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells
por: Thomas, Melvin E., et al.
Publicado: (2021)

MTH1 protects platelet mitochondria from oxidative damage and regulates platelet function and thrombosis
por: Ding, Yangyang, et al.
Publicado: (2023)

ATS MD’s in 2016
por: Fartoukh, Stephane, et al.
Publicado: (2016)

Software needs for MDs
por: Ruggiero, F
Publicado: (1993)

LHC MDS For 2018
por: Tomás, R, et al.
Publicado: (2019)

Bogus "M.Ds."
por: Karnik, C. H.
Publicado: (1929)

Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial
por: Garcia-Manero, Guillermo, et al.
Publicado: (2022)

Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype
por: Sallman, David A., et al.
Publicado: (2016)

Methods to Determine the Lagrangian Shear Experienced by Platelets during Thrombus Growth
por: Pinar, Isaac P., et al.
Publicado: (2015)

Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow – A proof of concept study
por: Nørgaard, Caroline Holm, et al.
Publicado: (2018)

CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022)

Proteolytic processing of platelet receptors
por: Gardiner, Elizabeth E.
Publicado: (2018)

Results of MD’s in Autumn 1988 on e+
por: Canard, B, et al.
Publicado: (1989)

Bone marrow CD3 (+) CD56 (+) regulatory T lymphocytes (T(R3) (−56) cells) are inversely associated with activation and expansion of bone marrow cytotoxic T cells in IPSS‐R very‐low/low risk MDS patients
por: Leone, Stefania, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_82am30q916j9pqmvb4pnk67qlj